名稱 | β-thalassemia mutation Reference Standard Ⅸ |
型號 | CBPD0009 |
報價 | |
特點(diǎn) | β-thalassemia mutation Reference Standard Ⅸ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 【產(chǎn)品推介】GLP1藥靶模型
- 科佰生物提前祝大家中秋快樂,闔家團(tuán)圓!
- 【產(chǎn)品推介】腫瘤融合基因檢測及靶向治療
- 細(xì)胞株開發(fā)的主要過程要知道
- ATCC細(xì)胞系的細(xì)胞培養(yǎng)步驟
- BCR-ABL激酶抑制劑細(xì)胞篩選模型
- 重磅!科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- 細(xì)胞株培養(yǎng)對于培養(yǎng)液的要求及相關(guān)常識說明
- 腫瘤細(xì)胞調(diào)控關(guān)鍵因子和機(jī)制的研究講解
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0009β-thalassemia mutation Reference Standard Ⅸ
- 詳細(xì)內(nèi)容
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Mutation 1 | Variation site: IVS-I-1(G>A) |
DNA Change: c.92+1G>A | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248159C>T | |
Transcript: NM_000518.5 | |
Mutation 2 | Variation site: IVS-I-6(T>C) |
DNA Change: c.92+6T>C | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248154A>G | |
Transcript: NM_000518.5 | |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. IVS-I-1(G>A) Heterozygous Figure 2. IVS-I-6(T>C) Heterozygous |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |